Clinical Trial Update: Autologous Stem Cell Therapy in Patients With Multiple System Atrophy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update notes an autologous stem cell therapy for Multiple System Atrophy that is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• Autologous stem cell therapy

Snippet

Sponsor: Biocells Medical | Conditions: MSA - Multiple System Atrophy, MSA | Phase 2 | Status: NOT_YET_RECRUITING